Riskpilot← Back to searchSign inGet full accessHovåsläkare AB
ABActiveOrg 5591295299Billdals Kyrkväg 18General medical practice activities · NACE 8621Est. 20171 employees
Revenue 2025
SEK 297K
+71% vs 2024
EBITDA margin
57.3%
+16186% vs 2024
Equity ratio
86.6%
Financial strength
Net profit 2025
SEK 135K
+2831% vs 2024
| Revenue | SEK 297K | +71% |
| EBITDA | SEK 170K | +16186% |
| Net profit | SEK 135K | +2831% |
| Total assets | SEK 217K | +298% |
| Equity | SEK 187K | +255% |
| Employees | 1 | — |
Legal name
Hovåsläkare AB
Org number
5591295299
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
17 oktober 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva läkarvård, konsult hos vårdgivare med ansvar för vård och omsorg samt utbildning inom vård och omsorg. Äga och förvalta värdepapper och handel med fast egendom samt därmed förenlig verksamhet.
Address
Billdals Kyrkväg 18
Email
demir.djekic@gu.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 98 | 1 012 | 385 | 174 | 297 |
| Staff expenses | — | −3 | — | −11 | −16 |
| EBITDA | 64 | 898 | 199 | −1 | 170 |
| Depreciation & amort. | −0 | — | −0 | — | — |
| EBIT | 64 | 898 | 199 | −1 | 170 |
| Net financials | — | — | −1 | −4 | −1 |
| Profit before tax | 64 | 898 | 199 | −5 | 170 |
| Tax | −14 | −185 | −41 | — | −35 |
| Net profit | 50 | 713 | 158 | −5 | 135 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 99 | 387 | 475 | 54 | 217 |
| Equity | 66 | 779 | 208 | 53 | 187 |
| Long-term debt | 0 | — | 0 | — | — |
| Short-term debt | 33 | −392 | 268 | 2 | 29 |
| Total debt | 33 | −392 | 268 | 2 | 29 |
EBITDA margin
57.3%
This company
15.8%
Market median
+263% vs market
20212025
Equity ratio
86.6%
This company
38.2%
Market median
+127% vs market
20212025
Return on equity
71.8%
This company
18.4%
Market median
+290% vs market
20212025
Net profit margin
45.3%
This company
8.1%
Market median
+459% vs market
20212025
Asset turnover
1.37×
This company
1.12×
Market median
+22% vs market
20212025
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DD Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Board of Directors | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hovåsläkare AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Demir Djekic | Chief Executive Officer | 0 companies |
| Mohamed Abdulkadir Ahmed | Board of Directors | 0 companies |
| Hesham Ahemad Abdlwahed Hamamche | Deputy Board Member | 0 companies |